Success Metrics

Clinical Success Rate
73.9%

Based on 34 completed trials

Completion Rate
74%(34/46)
Active Trials
1(1%)
Results Posted
47%(16 trials)
Terminated
12(18%)

Phase Distribution

Ph phase_1
9
13%
Ph phase_3
13
19%
Ph phase_4
6
9%
Ph phase_2
21
31%
Ph early_phase_1
1
1%
Ph not_applicable
17
25%

Phase Distribution

10

Early Stage

21

Mid Stage

19

Late Stage

Phase Distribution67 total trials
Early Phase 1First-in-human
1(1.5%)
Phase 1Safety & dosage
9(13.4%)
Phase 2Efficacy & side effects
21(31.3%)
Phase 3Large-scale testing
13(19.4%)
Phase 4Post-market surveillance
6(9.0%)
N/ANon-phased studies
17(25.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

34 of 51 finished

Non-Completion Rate

33.3%

17 ended early

Currently Active

1

trials recruiting

Total Trials

68

all time

Status Distribution
Active(1)
Completed(34)
Terminated(17)
Other(16)

Detailed Status

Completed34
unknown16
Terminated12
Withdrawn5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
68
Active
1
Success Rate
73.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.5%)
Phase 19 (13.4%)
Phase 221 (31.3%)
Phase 313 (19.4%)
Phase 46 (9.0%)
N/A17 (25.4%)

Trials by Status

recruiting11%
unknown1624%
completed3450%
terminated1218%
withdrawn57%

Recent Activity

Clinical Trials (68)

Showing 20 of 68 trialsScroll for more
NCT06617182Phase 2

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

Recruiting
NCT05655819Phase 1

A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia

Completed
NCT05856188Not Applicable

Efficacy of Glutamine in Management of Radiation Mucositis

Unknown
NCT03867214Phase 4

Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis

Unknown
NCT05569993Early Phase 1

Glutamine and Traumatic Brain Injury

Unknown
NCT01952847Phase 3

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

Terminated
NCT03517254Not Applicable

Use of Glutamine for Recovery Muscle Strength

Unknown
NCT04909905Phase 3

Glutamine Supplementation and Short-term Mortality in Covid-19

Completed
NCT05054517

Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity

Completed
NCT04388371Phase 1

Glutamine PET Imaging in LAM

Completed
NCT01467063Not Applicable

Glutamine and Insulin Sensitivity in Type I Diabetes

Completed
NCT04710290Phase 2

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

Unknown
NCT00133978Not Applicable

Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients

Completed
NCT01576003Not Applicable

Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

Completed
NCT01704664Not Applicable

Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients

Unknown
NCT01983969Phase 1

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Completed
NCT02589145Phase 1

Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype

Terminated
NCT01783522Phase 2

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Terminated
NCT02012608Phase 2

Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

Terminated
NCT03917095Not Applicable

The Safety and Efficacy of TET Enema in the Treatment of UC

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
68